1h Free Analyst Time
The 3d bioprinting market is forecasted to grow by USD 2015.81 mn during 2022-2027, accelerating at a CAGR of 19.94% during the forecast period. The report on the 3d bioprinting market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cost efficiency and enhanced productivity, advancements in 3d bioprinting technology, and increased demand for personalized or customized orthopedic devices.
The 3d bioprinting market is segmented as below:
By Application
- Human tissue and organ generation
- Medical testing
- Dental
- Prosthetics
- Others
By Solution
- 3d bioprinters
- Bioprinting materials
- Services and ancillary equipment
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the 3d bioprinting market covers the following areas:
- 3d bioprinting market sizing
- 3d bioprinting market forecast
- 3d bioprinting market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Solution
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global 3d bioprinting market: 3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is developments in scaffold-free bioprinting.'
According to the report, one of the major drivers for this market is the rising cost efficiency and enhanced productivity.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Bioprinting Solutions
- 3D Systems Corp.
- Advanced Solutions Inc.
- Aspect Biosystems Ltd.
- BICO Group AB
- CollPlant Biotechnologies Ltd.
- Cyfuse Biomedical K.K.
- Desktop Metal Inc.
- Foldink
- GE Healthcare Technologies Inc.
- Hangzhou Jienuofei Biotechnology Co. Ltd.
- Inventia Life Science Pty Ltd.
- Organovo Holdings Inc.
- Pandorum Technologies Pvt. Ltd.
- Poietis
- Precise Bio Inc.
- regenHU Ltd.
- ROKIT Healthcare Inc.